跳至主要内容
临床试验/IRCT201103065563N3
IRCT201103065563N3已完成未知

Surgical versus medical treatment for abnormal uterine bleeding in premenopausal women

Vice Chancellor for Research, Tabriz University of Medical Sciences0 个研究点目标入组 97 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
97

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 55 years(—)
性别
Female

入选标准

  • Premenopausal women between 40-55 years old with abnormal uterine bleeding for at least 2 months which is described as bleeding more than 7 days in a month or heavy bleeding resulting in anemia (Hct<32%), no evidence for atypical heperplasia or carcinoma in D&C, no response to simple medications such as medroxy progetrone and contraceptive tablets, no Ovarian or uterine organic lesions (ruled out by using clinical examination and ultrasonography)
  • Exclusion criteria: Anemia for other reasons, Fertility preservation, Evidence of pregnancy, Endocrinopathy, Coagulopathy, contraindications for medical treatment, Using IUD

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Tabriz University of Medical Sciences

相似试验

Surgical versus medical treatment for abnormal... | 临床试验